Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 5,000 shares at $20.00 ($100K) on 2013-11-08, disclosed to the SEC on 2013-11-12.
Open-market sale of $100k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 652 | $13K | 13.0% |
| 2 | $20.00 | 4,348 | $87K | 87.0% |
| Total | $20.00 avg | 5,000 | $100K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |